- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Wiener index.
Displaying page 1 of 1.
| EudraCT Number: 2017-003240-20 | Sponsor Protocol Number: 16-058 | Start Date*: 2017-10-12 |
| Sponsor Name:RWTH Aachen, represented by the rector, himself represented by the dean of the Medical Faculty | ||
| Full Title: Velphoro and impact on the oral cavity and gut microbiome | ||
| Medical condition: Hyperphosphatemia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-003418-15 | Sponsor Protocol Number: SSP | Start Date*: 2012-10-23 |
| Sponsor Name:Medizinische Universität Wien | ||
| Full Title: Methylphenidate modified release as treatment option of MS-associated fatigue. A single-center randomized double-blind placebo-controlled trial. | ||
| Medical condition: Fatigue is a very common symptom in multiple sclerosis. Its management comprises nonpharmacologic approaches like exercise, cooling procedures and energy conservation programs and as second step ph... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003498-41 | Sponsor Protocol Number: D-Fampr | Start Date*: 2015-09-22 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Effects of dalfampridine on mobility in the context of daily life | ||
| Medical condition: Motor behaviour and cognition in multiple sclerosis patients | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-001324-19 | Sponsor Protocol Number: BDS_18_01 | Start Date*: 2018-08-02 | |||||||||||||||||||||
| Sponsor Name:Marinomed Biotech AG | |||||||||||||||||||||||
| Full Title: Demonstration of therapeutic equivalence/non-inferiority as well as early onset of action of the novel water-soluble budesonide nasal spray (Budesolv) compared with marketed Rhinocort® aqua 64 in p... | |||||||||||||||||||||||
| Medical condition: Allergic Rhinitis/ Rhinoconjunctivitis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.